The George Washington University Biostatistics Center
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, The George Washington University Biostatistics Center sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).
The George Washington University Biostatistics Center: 24 sponsored US clinical trials, 3 recruiting.
The George Washington University Biostatistics Center sponsors 24 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 16 completed. 17 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obstetrical Complications, with 3 trials.
Top-decile sponsor footprint
The George Washington University Biostatistics Center ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (76.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
24 total, page 1 of 1
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
NCT06980025
Azithromycin Prophylaxis for PRElabor CEsarean DElivery Trial
NCT06605118
Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy
NCT03487185
Opioid Prescription After Cesarean Trial
NCT04296396
Maternal Morbidity and Mortality During the COVID-19 Pandemic
NCT04519502
Pravastatin to Prevent Preeclampsia
NCT03944512
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean
NCT03364491
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
NCT02901626
A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix
NCT02518594
A Randomized Trial of Induction Versus Expectant Management
NCT01990612
An Observational Study of Hepatitis C Virus in Pregnancy
NCT01959321
A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
NCT01376778
Fetal ST Segment and T Wave Analysis in Labor
NCT01131260
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
NCT01222247
RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix
NCT00439374
Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy
NCT00388297
Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies
NCT00135902
Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)
NCT00099164
Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)
NCT00135707
Management of Myelomeningocele Study (MOMS)
NCT00060606
Gestational Diabetes Mellitus Trial (GDM)
NCT00069576
Fetal Pulse Oximetry Trial (FOX)
NCT00098709
Repeat Antenatal Steroids Trial
NCT00015002
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
NCT00014989
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 17 |
Where The George Washington University Biostatistics Center enrollment is open (later-stage tilt)
3 recruiting of 24 indexed (13% open); 16 completed (67%).
Phase mix: 17 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Obstetrical Complications (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
The George Washington University Biostatistics Center: open-pipeline peers nationwide
Peers matched on 24 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
The George Washington University Biostatistics Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 24 trials (± recruiting share)
- Acrotech Biopharma · 24 trials · 8% recruiting
- Agenus · 24 trials · 0% recruiting
- Akebia Therapeutics · 24 trials · 4% recruiting
- Blueprint Medicines Corporation · 24 trials · 25% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this The George Washington University Biostatistics Center page
24 registered trials is a research-attention snapshot, not an endorsement of The George Washington University Biostatistics Center or any single study.
- 3 of The George Washington University Biostatistics Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obstetrical Complications is the condition The George Washington University Biostatistics Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obstetrical Complications trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
The George Washington University Biostatistics Center pipeline card: 24 registered trials from official public datasets.Report a data error.